Bronchopulmonary dysplasia (BPD) is a common and severe complication of very preterm birth. Dr. Jensen’s research seeks to improve the long-term respiratory health of premature infants through: (1) clinical and translational studies that aim to develop evidence-based strategies to prevent and treat BPD; (2) novel characterization of disease severity and phenotypes in BPD; and (3) application of health services research techniques to investigate the association between hospital-level factors and neonatal morbidity and mortality.

Dr. Jensen’s research is supported by grant funding from the National Heart Lung and Blood Institute (NHLBI), the National Institute of Child Health and Human Development (NICHD), and the American Lung Association (ALA). He is a member of the International BPD Collaborative pharmacology working group and the International Neonatal Consortium (INC) BPD working group.

BA, Pomona College (Chemistry), 2003

MD, University of Washington School of Medicine, 2007

Fellowship, Children's Hospital of Philadelphia (Neonatology), 2014

MSCE, University of Pennsylvania (Clinical Trials), 2015

Attending Neonatologist

Assistant Professor of Pediatrics

American Academy of Pediatrics, 2016-

Society for Pediatric Research, 2017-

Patient-Oriented Research Award Winner, Children's Hospital of
Philadelphia, 2014

Eastern Society for Pediatric Research Faculty Young Investigator Award, 2015

American Association of SIDS Prevention Physicians Annual Conference
Travel Award, 2017

Finalist for Impact Article of the Year - Evidence Based Neonatology (EBNeo) Consortium, 2019

American Society for Clinical Investigation Young Physician-Scientist Award, 2021